← Leaderboards
Ravindra K Pandey
Roswell Park Cancer Institute Corp
$10,848,714
Attributed
$10,848,714
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,848,714 · 8
By mechanism
R01$4,333,409 · 2
P01$4,318,259 · 3
R33$1,425,000 · 1
R21$772,046 · 2
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Sandra O Gollnick$8,125,802
- Heinz Baumann$4,783,902
- Todd Lyle Demmy$539,843
- Chukwumere E. Nwogu$1,268,391
- Allan R Oseroff$3,139,346
Others in their field
Top investigators on “Photosensitizing Agents”
- Tayyaba Hasan · Massachusetts General Hospital$10,180,335
- Margaret Rita Karagas · Dartmouth College$8,936,094
- Samuel Achilefu · Ut Southwestern Medical Center$6,867,809
- Theresa M Busch · University Of Pennsylvania$5,577,937
- Thomas Harrison Foster · University Of Rochester$5,405,508
- Edward V. Maytin · Cleveland Clinic Foundation$4,756,367
Research focus
Photosensitizing AgentsTumorCellsIn VivoCharacteristicsPropertyAnalogMalignant NeoplasmsNeoplastic CellGenerationsPhotochemotherapyPhototoxicityImageUptakeHpphIn VitroToxic EffectTreatment EfficacyModalityBaseDrug KineticsLightPositron-Emission TomographyTissues
Grant awards (27)
Project 2: Optimization of HPPH for HNSCC Selectivity$835,509
P01 · FY2019 · CA · contact PI
Project 2: Optimization of HPPH for HNSCC Selectivity$533,840
P01 · FY2018 · CA · contact PI
Project 2: Optimization of HPPH for HNSCC Selectivity$205,583
P01 · FY2017 · CA · contact PI
Project 2: Optimization of HPPH for HNSCC Selectivity$523,814
P01 · FY2016 · CA · contact PI
Project 2: Optimization of HPPH for HNSCC Selectivity$550,988
P01 · FY2015 · CA · contact PI
Development of Agents for Optimization of Photodynamic Therapy and Tumor Imaging$251,628
P01 · FY2013 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$560,188
R01 · FY2012 · CA · contact PI
Development of Agents for Optimization of Photodynamic Therapy and Tumor Imaging$302,844
P01 · FY2012 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$564,220
R01 · FY2011 · CA · contact PI
Development of Agents for Optimization of Photodynamic Therapy and Tumor Imaging$309,363
P01 · FY2011 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$62,572
R01 · FY2011 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$584,339
R01 · FY2010 · CA · contact PI
Development of Agents for Optimization of Photodynamic Therapy and Tumor Imaging$312,124
P01 · FY2010 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$64,506
R01 · FY2010 · CA · contact PI
Novel Cancer Nanotechnology Platforms for Photodynamic Therapy and Imaging$655,037
R01 · FY2009 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$578,886
R01 · FY2009 · CA · contact PI
Development of Agents for Optimization of Photodynamic Therapy and Tumor Imaging$303,912
P01 · FY2009 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$62,627
R01 · FY2009 · CA · contact PI
Novel Cancer Nanotechnology Platforms for Photodynamic Therapy and Imaging$644,847
R01 · FY2008 · CA · contact PI
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors$556,187
R01 · FY2008 · CA · contact PI
Development/Bifunctional MR Agents/Diagnosis and Therapy$706,106
R33 · FY2007 · CA · contact PI
Radiopharmaceuticals for Tumor Imaging and Photodynamic Therapy$180,131
R21 · FY2007 · CA · contact PI
Development/Bifunctional MR Agents/Diagnosis and Therapy$718,894
R33 · FY2006 · CA · contact PI
Radiopharmaceuticals for Tumor Imaging and Photodynamic Therapy$177,879
R21 · FY2006 · CA · contact PI
Development/Bifunctional MR Agents/Diagnosis and Therapy$208,416
R21 · FY2005 · CA
Development/Bifunctional MR Agents/Diagnosis and Therapy$205,620
R21 · FY2004 · CA
Project 1$188,654
P01 · FY2003 · CA